drugset / Trial / NCT03581877

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

NCT03581877

Phase 4 Active not recruiting 31 enrolled Northwell Health
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether peripheral low dose systemic thrombolysis (PLST) is non-inferior to catheter directed acoustic pulse thrombolysis (ACDT) in improving RV function and reducing pulmonary artery pressures in submassive pulmonary embolism (PE)

Timeline

Start
2019-01-28
Primary completion
2023-03-19
Completion
2025-03-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 24 mg